QB3@953 Companies Attract $1.36B In Capital

We’re here for the entrepreneurs

QB3@953 Companies Attract $1.36B In Capital

San Francisco, CA, May 1, 2017 – QB3@953 proved definitively that its incubator facilities allow life science startups to progress at lightening speed, making a huge impact on the life-science ecosystem of the Bay Area.

QB3@953 tenant and alumni companies are thriving. In the three short years since its founding, QB3@953 companies attracted $1.36Bn in investments and acquisitions.

Clearly, QB3@953 is fulfilling its mission of “enabling awesome”. Renting small units of space in a state-of-the-art biolab facility also allows a more diverse set of entrepreneurs the chance to become great. For instance, of the 94 resident and alumni companies, 11 of them are lead by women, a much higher percentage than in the industry as a whole.

The incubator building in San Francisco’s Dogpatch neighborhood supports 35-45 ambitious startups, providing them lab space, connecting them with venture funding, and offering business services. Most businesses outgrow and “graduate” from the incubator into their own lab within two years, but remain part of the QB3@953 family.

“QB3@953 has had remarkable success in attracting the best entrepreneurial scientists,” said Doug Crawford, General Manager. “We are proud to have been able to help them achieve so much in such a short time.”

Crawford also points out that this constellation of exciting startups has attracted support from an ever growning set of partners that includes J&J, Amgen, GSK, Pfizer, L’Oreal and Servier. “We provide an opportunity for the largest and smallest companies to work together – ensuring that the startups are focused on the most important quesitons and accelerating early collaborations,” says Crawford.


Douglas Crawford, General Manager
Ph: 415-205-4825

Upcoming Event

  • Scalable Microbiome Diagnostics for Agriculture

    1st Floor Conference Room, GEHC
    953 Indiana Street, San Francisco, CA 94107, United States
    AMGEN Lunch Seminar Diane Wu, PhD and Poornima Parameswaran, PhD Co-Founders, Trace Genomics RSVP The Trace Genomics microbiome sequencing platform enables screening of disease-causing microbes and interpretation of millions of beneficial organisms in the soil. Their machine learning platform enables simple integration of soil microbiome information into with field management information to help farmers identify optimal management conditions that increase soil health and sustainability as well as crop yields. Their innovative technology has received notable media coverage in Forbes, TechCrunch, Wall Street Journal, AgFunder, and Fast Company, and was most recently listed by Forbes as one of the 25 most innovative Ag Tech startups. About Diane Wu Diane Wu, PhD completed a BSc in Computer Science and Molecular Biology at SFU (Vancouver, Canada) and a PhD in Genetics at Stanford University. She was awarded a Stanford Graduate Fellowship and published her thesis on the cover of Nature Structural Molecular Biology, advised by Nobel Laureate Dr. Andrew Fire. Diane then joined the machine learning team at Palantir Technologies as one of their first data scientists, where she built predictive models for healthcare, merchandising, law enforcement, and fraud detection.
    About Poornima Parameswaran Poornima Parameswaran, PhD completed her BS in Molecular Biology at UT Austin, a PhD in Microbiology & Immunology at Stanford University with Nobel Laureate Dr. Andrew Fire, and her postdoctoral fellowship with MacArthur Fellow Dr. Eva Harris at UC Berkeley's school of Public Health, where she also worked with the Ministry of Health in Nicaragua. She has been an author on eleven publications (371+ citations), where she used NGS technologies in novel ways to address fundamental questions in pathogen-host interactions.


953 Indiana St., San Francisco, CA 94107
Tel: (415)-347-8287

Sign-Up for our Newsletter